Published in J Virol on August 01, 1998
Comprehensive comparative analysis of strand-specific RNA sequencing methods. Nat Methods (2010) 9.09
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res (2007) 2.49
Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. J Virol (2000) 1.88
Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein. J Virol (2002) 1.39
Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus. J Virol (2000) 1.36
Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription. RNA Biol (2010) 1.35
Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription. RNA (2001) 1.34
Single-molecule FRET studies of important intermediates in the nucleocapsid-protein-chaperoned minus-strand transfer step in HIV-1 reverse transcription. Biophys J (2005) 1.26
Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: analysis in reconstituted and endogenous reverse transcription systems. J Virol (1999) 1.22
Effects of nucleic acid local structure and magnesium ions on minus-strand transfer mediated by the nucleic acid chaperone activity of HIV-1 nucleocapsid protein. Nucleic Acids Res (2007) 0.89
Actinomycin D induces high-level resistance to thymidine analogs in replication of human immunodeficiency virus type 1 by interfering with host cell thymidine kinase expression. J Virol (2003) 0.85
The nature of actinomycin D binding to d(AACCAXYG) sequence motifs. Nucleic Acids Res (2004) 0.82
Identification and characterization of a novel Mdm2 splice variant acutely induced by the chemotherapeutic agents adriamycin and actinomycin D. Cell Cycle (2008) 0.77
Structural Insights into the HIV-1 Minus-strand Strong-stop DNA. J Biol Chem (2015) 0.76
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (1970) 19.89
RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature (1970) 19.38
A detailed model of reverse transcription and tests of crucial aspects. Cell (1979) 8.93
RNA chaperones and the RNA folding problem. J Biol Chem (1995) 5.67
Actinomycin and nucleic acid function. Prog Nucleic Acid Res Mol Biol (1964) 5.00
Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science (1998) 4.52
Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem Sci (1998) 3.78
First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J Mol Biol (1995) 3.63
Interactions of retroviral structural proteins with single-stranded nucleic acids. J Biol Chem (1987) 3.62
Forms of deoxyribonucleic acid produced by virions of the ribonucleic acid tumor viruses. J Virol (1971) 3.45
Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol (1974) 3.37
Studies of the binding of actinomycin and related compounds to DNA. J Mol Biol (1968) 3.35
An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J (1994) 2.96
DNA polymerases of Rous sarcoma virus: delineation of two reactions with actinomycin. Nature (1970) 2.93
DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J Virol (1994) 2.89
THE PARTICIPATION OF DNA IN ROUS SARCOMA VIRUS PRODUCTION. Virology (1964) 2.70
THE ROLE OF DEOXYRIBONUCLEIC ACID IN THE SYNTHESIS OF ROUS SARCOMA VIRUS. Virology (1964) 2.70
THE EFFECTS OF ACTINOMYCIN D ON GROWTH OF ROUS SARCOMA VIRUS IN VITRO. Virology (1963) 2.68
Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities. Proc Natl Acad Sci U S A (1992) 2.64
Envelope sequences of two new United States HIV-1 isolates. Virology (1988) 2.44
Reverse transcriptase.RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. J Biol Chem (1991) 2.36
Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res (1993) 2.32
Stereochemistry of actinomycin binding to DNA. II. Detailed molecular model of actinomycin-DNA complex and its implications. J Mol Biol (1972) 2.31
The DNA provirus hypothesis. Science (1976) 2.31
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc Natl Acad Sci U S A (1996) 2.30
Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J Biol Chem (1992) 2.21
Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J (1994) 2.16
Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science (1995) 2.16
Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J Virol (1998) 2.14
Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc Natl Acad Sci U S A (1976) 2.14
Isolation of a ribonucleoprotein structure from oncornaviruses. J Virol (1973) 2.11
Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry (1994) 2.08
Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J Biol Chem (1994) 2.07
In vitro synthesis of infectious DNA of murine leukaemia virus. Nature (1977) 2.06
Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA. J Virol (1979) 2.04
Dependence of Moloney murine leukemia virus production on cell growth. Virology (1975) 2.04
Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry (1996) 1.84
Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J Virol (1996) 1.83
Studies on the binding of actinomycin D to DNA and DNA model polymers. J Mol Biol (1970) 1.81
Chemotherapy in the treatment of leukemia and Wilms' tumor. JAMA (1966) 1.79
Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J (1994) 1.77
Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J Virol (1976) 1.69
Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1. J Biol Chem (1997) 1.62
Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract. J Virol (1996) 1.53
Inhibition of Rauscher murine leukemia virus growth in vitro by actinomycin D. Virology (1967) 1.53
HIV nucleocapsid protein. Expression in Escherichia coli, purification, and characterization. J Biol Chem (1993) 1.52
Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity. Protein Sci (1993) 1.52
EFFECTS OF ACTINOMYCIN D AND OF MITOMYCIN C ON THE DEVELOPMENT OF ROUS SARCOMA VIRUS. Virology (1964) 1.49
Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J Mol Biol (1997) 1.49
Native ribonucleoprotein is an efficient transcriptional complex of avian myeloblastosis virus. Proc Natl Acad Sci U S A (1980) 1.29
Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of a Ki-ras ribozyme in vitro. J Mol Biol (1994) 1.29
Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D. J Mol Biol (1992) 1.27
Defects in primer-template binding, processive DNA synthesis, and RNase H activity associated with chimeric reverse transcriptases having the murine leukemia virus polymerase domain joined to Escherichia coli RNase H. Biochemistry (1995) 1.18
Interactions of murine leukemia virus core components: characterization of reverse transcriptase packaged in the absence of 70S genomic RNA. J Virol (1977) 1.17
Metabolism of viral RNA in murine leukemia virus-infected cells; evidence for differential stability of viral message and virion precursor RNA. J Virol (1981) 1.17
A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities. Biochemistry (1993) 1.09
Binding specificities of actinomycin D to self-complementary tetranucleotide sequences -XGCY-. Biochemistry (1988) 1.04
Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases. Biochemistry (1996) 1.03
Human immunodeficiency virus nucleocapsid protein stimulates strand transfer from internal regions of heteropolymeric RNA templates. Arch Virol (1995) 1.03
Inhibition of mouse leukemia virus (MLV) replication by actinomycin D. Virology (1967) 1.03
Actinomycin D and 7-aminoactinomycin D binding to single-stranded DNA. Biochemistry (1991) 1.02
Binding of actinomycin D to the T(G)nT motif of double-stranded DNA: determination of the guanine requirement in nonclassical, non-GpC binding sites. Biochemistry (1994) 1.01
Elongation of DNA complementary to the 5' end of the avian sarcoma virus genome by the virion-associated RNA-dependent DNA polymerase. J Virol (1979) 0.98
Site-specific binding constants for actinomycin D on DNA determined from footprinting studies. Biochemistry (1992) 0.95
Chemotherapy of gestational choriocarcinoma. Cancer (1972) 0.93
Functional analysis of reverse transcription by a frameshift pol mutant of murine leukemia virus. Virology (1985) 0.92
Selectivity of F8-actinomycin D for RNA:DNA hybrids and its anti-leukemia activity. Bioorg Med Chem (1997) 0.81
Effect of actinomycin D on nucleic acid hybridization: the cause of erroneous DNA elongation during DNA synthesis of RNA tumor viruses in vitro. Biochim Biophys Acta (1980) 0.78
Map-based cloning of a protein kinase gene conferring disease resistance in tomato. Science (1993) 9.00
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc Natl Acad Sci U S A (1988) 6.44
Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol (1990) 5.45
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science (1992) 5.25
Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification. Proc Natl Acad Sci U S A (1983) 5.12
Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol (1998) 5.05
Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein. Science (1985) 3.97
Superconductivity at 43 K in SmFeAsO1-xFx. Nature (2008) 3.80
Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem Sci (1998) 3.78
Interactions of retroviral structural proteins with single-stranded nucleic acids. J Biol Chem (1987) 3.62
Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol (1974) 3.37
The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J Virol (1993) 3.29
Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology (1997) 3.24
Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J Biol Chem (1981) 3.21
Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. J Immunol (1984) 3.07
Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins. J Virol (1987) 3.02
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother (1997) 2.98
Fatty acylation of proteins. Annu Rev Cell Biol (1988) 2.92
Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J Virol (1984) 2.91
Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus. Proc Natl Acad Sci U S A (1978) 2.87
Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci (1992) 2.79
Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses. J Virol (1986) 2.77
Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol (1996) 2.65
A micromethod for complete removal of dodecyl sulfate from proteins by ion-pair extraction. Anal Biochem (1979) 2.57
Purification and N-terminal amino acid sequence comparisons of structural proteins from retrovirus-D/Washington and Mason-Pfizer monkey virus. J Virol (1985) 2.43
A member of the tomato Pto gene family confers sensitivity to fenthion resulting in rapid cell death. Plant Cell (1994) 2.39
Primary structure of human carbonic anhydrase C. J Biol Chem (1976) 2.38
Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses. J Virol (1992) 2.36
Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure. J Virol (1984) 2.32
Separation of amino acid phenylthiohydantoins by high-performance liquid chromatography on phenylalkyl support. Anal Biochem (1980) 2.30
Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem (1987) 2.30
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc Natl Acad Sci U S A (1996) 2.30
Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem (1995) 2.20
Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J Virol (2001) 2.17
Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science (1995) 2.16
Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc Natl Acad Sci U S A (1976) 2.14
Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J Virol (1998) 2.14
Distance-dependent electron transfer in DNA hairpins. Science (1997) 2.13
Analysis of arbovirus ribonucleic acid forms by polyacrylamide gel electrophoresis. J Virol (1971) 2.10
Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation (1994) 2.08
Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA. J Virol (1979) 2.04
T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Cell Immunol (1984) 2.01
Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res Hum Retroviruses (1995) 2.01
Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine. AIDS Res Hum Retroviruses (1998) 1.97
Translational suppression in retroviral gene expression. Adv Virus Res (1992) 1.93
Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule. J Virol (1979) 1.90
Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. J Virol (2000) 1.88
Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction. Hum Reprod (2009) 1.87
Neutron-diffraction measurements of magnetic order and a structural transition in the parent BaFe2As2 compound of FeAs-based high-temperature superconductors. Phys Rev Lett (2008) 1.86
Membrane-associated replication complex in arbovirus infection. J Virol (1972) 1.83
Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J Virol (1996) 1.83
Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest (1996) 1.82
Localization of DNA binding activity of HIV-1 integrase to the C-terminal half of the protein. AIDS Res Hum Retroviruses (1992) 1.82
Characterization of mouse mammary tumor virus gag-pro gene products and the ribosomal frameshift site by protein sequencing. Proc Natl Acad Sci U S A (1987) 1.81
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A (1998) 1.81
The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochemistry (1990) 1.77
Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J Virol (1990) 1.75
Effect of polymerase mutations on packaging of primer tRNAPro during murine leukemia virus assembly. J Virol (1981) 1.66
Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. Homology with human insulin-like growth factor II. J Biol Chem (1981) 1.65
Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature (1993) 1.63
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol (1995) 1.63
A novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4. Mol Cell Biol (1994) 1.62
Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62
Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst Rev (2008) 1.60
Amino-terminal amino acid sequence and carboxyl-terminal analysis of Rauscher murine leukemia virus glycoproteins. Virology (1978) 1.59
Amino-terminal sequence of bovine leukemia virus major internal protein: homology with mammalian type C virus p30 structural proteins. Proc Natl Acad Sci U S A (1979) 1.57
Intramedullary spinal tuberculomas during treatment of tuberculous meningitis. Clin Neurol Neurosurg (1994) 1.57
Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli. J Virol (1986) 1.55
Specific membranous structures associated with the replication of group A arboviruses. J Virol (1972) 1.54
Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL 2. J Immunol (1984) 1.54
Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract. J Virol (1996) 1.53
The medical student global health experience: professionalism and ethical implications. J Med Ethics (2008) 1.53
N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem Biophys Res Commun (1987) 1.51
A rapid, large scale purification procedure for gibbon interleukin 2. J Immunol (1983) 1.51
Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol (1987) 1.49
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48
Single domain spin manipulation by electric fields in strain coupled artificial multiferroic nanostructures. Phys Rev Lett (2013) 1.48
Chromatographic analysis of the aminoacyl-tRNAs which are required for translation of codons at and around the ribosomal frameshift sites of HIV, HTLV-1, and BLV. Virology (1989) 1.47
The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea. Int J Clin Pract (2007) 1.46
Computerized mass detection for digital breast tomosynthesis directly from the projection images. Med Phys (2006) 1.46
Leptotrichia buccalis bacteremia in patients with cancer: report of four cases and review. Rev Infect Dis (1991) 1.46
Anisotropy in the electrical resistivity and susceptibility of superconducting BaFe2As2 single crystals. Phys Rev Lett (2009) 1.45
Identification of amino acids inserted during suppression of UAA and UGA termination codons at the gag-pol junction of Moloney murine leukemia virus. Proc Natl Acad Sci U S A (1990) 1.45
Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44
A two-degree-of-freedom hip exoskeleton device for an immature animal model of exercise-induced Legg-Calvé-Perthes disease. Proc Inst Mech Eng H (2009) 1.42